The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia
Saved in:
Horyniak, D., et al., The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia. International Journal of Drug Policy, Vol. 22, no. 2 (2011), p. 167-171.
Ref.
178170
Location:
SIIS R.1114 Archivo
Palabras clave:
Buprenorfina, Drogas ilegales, Drogodependencias, Efectos, Opiáceos, Recaída, Reducción de daños, Tratamiento médico, Australia
Buprenorfina, Drogas ilegales, Drogodependencias, Efectos, Opiáceos, Recaída, Reducción de daños, Tratamiento médico, Australia
Similar Items: The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia
- ADHERENCE TO HIV TREATMENT AMONG IDUS AND THE ROLE OF OPIOID SUBSTITUTION TREATMENT (OST)
- SUBSTITUTION PHARMACOTHERAPIES FOR OPIOID ADDICTION: FROM METHADONE TO LAAM AND BUPRENORPHINE
- Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: Prevalence estimates and risk factors
- PREVALENCE OF DIVERSION AND INJECTION OF METHADONE AND BUPRENORPHINE AMONG CLIENTS RECEIVING OPIOID TREATMENT AT COMMUNITY PHARMACIES IN NEW SOUTH WALES, AUSTRALIA
- Compliance with buprenorphine medication-assisted treatment and relapse to opioid use
- Predictors of dropout from inpatient opioid detoxification with buprenorphine. A chart review